China's Lepu Biopharma falls in Hong Kong debut

Lepu Biopharma

23/02/2022 03:05

** Shares of tumor treatment-focused Lepu Biopharma Co Ltd
 2157.HK  trade as low as HK$6.77 per share in Hong Kong trading
debut on Wednesday, 5% below their global offering price
    ** Stock last down 3.1% from HK$7.13 offering price
    ** Shanghai-based biopharmaceutical company sold 126.88 mln
shares in global offering, raising HK$905 mln ($116 mln) to fund
clinical development and manufacturing of core products
 urn:newsml:reuters.com:*:nFWN2UK185
    ** Hang Seng Commerce & Industry Index  .HSNC  rises 1.1%
and healthcare index  .HSCIH  jumps 2.4%
    ** Hang Seng Composite Index  .HSCI  and the benchmark Hang
Seng Index  .HSI  both climb 0.6%
    
    ($1 = 7.8028 Hong Kong dollars)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))